CDK2-IN-50
CDK2-IN-50 is a CDK2 inhibitor (IC50 = 0.77 nM). CDK2-IN-50 can induce G1 phase arrest, indicating that it has an effective CDK2/cyclin E targeting mechanism. CDK2-IN-50 also has a significant pro-apoptotic effect. CDK2-IN-50 can be used for the study of breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C27H27N3O2S
- 分子量:457.59
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
CDK2/cyclinE 0.77 nM (IC50) |
CDK2-IN-50 (Compound 8b) (10 μM) exhibits significant growth-inhibiting activity, with an average GI% of 90.51%[1].
CDK2-IN-50 (0.01-100 μM) has a GI50 value as low as 0.33 μM (for breast cancer cell lines), with an average GI50 of 5.58 μM across the entire plate[1].
CDK2-IN-50 (0.33 μM, 24 h) causes cell cycle arrest in the G1 phase, with 77.92% of cells in the G1 phase in MDA-MB-468 cells[1].
CDK2-IN-50 (0.33 μM) induces early apoptosis in MDA-MB-468 cells at a rate of 15.21%, late apoptosis at a rate of 5.87%, and a total apoptosis rate of 21.08%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-468 cells
-
Concentration:0.33 μM
-
Incubation Time:24 h
-
Result:Caused cell cycle arrest in the G1 phase, with 77.92% of cells in the G1 phase.
化学情報
-
分子量 457.59
-
分子式 C27H27N3O2S
-
SMILES
O=C(NC1=CC=C(C)C=C1)C2=C(N)C3=C(S2)N=C4CCCCCC4=C3C5=CC=C(OC)C=C5
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
CDK2-IN-50 関連分類
HY-179231 関連分類
Powered by Bioz